← Leaderboards
Lakshmidevi None Pulakat
Mississippi State University
$3,422,081
Attributed
$4,717,107
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $919.3K · FY2013–21$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,717,107 · 3
By mechanism
R01$4,580,907 · 2
R15$136,200 · 1
Top collaborators
- Iris Z Jaffe5 shared
Others in their field
Top investigators on “Rodent Model”
- David Heimbrook · Leidos Biomedical Research, Inc.$173,257,325
- Polly Chang · Sri International$53,674,299
- Ed Lein · Allen Institute$41,433,793
- Neil Scott Lipman · Sloan-Kettering Inst Can Research$39,869,247
- Hongkui Zeng · Allen Institute$37,381,292
- Karl Alexander Deisseroth · Stanford University$35,775,407
Research focus
Rodent ModelPharmaceutical PreparationsNutrientRattusSerumCardiovascular SystemIn VitroNovel TherapeuticsPathway InteractionsPhosphotransferasesDiabeticAttenuatedBaseCause Of DeathChronicDiabetes MellitusBlood VesselsLiteratureAgonistObesityCardiovascular DiseasesEquilibriumEpidemicFunding
Grant awards (14)
Mechanisms for Sex Differences in CVD Pathology and Development of a Targeted Therapeutic$515,319
R01 · FY2021 · HL · contact PI
Mechanisms for Sex Differences in CVD Pathology and Development of a Targeted Therapeutic$692,975
R01 · FY2020 · HL · contact PI
Mechanisms for Sex Differences in CVD Pathology and Development of a Targeted Therapeutic$545,566
R01 · FY2019 · HL · contact PI
Mechanisms for Sex Differences in CVD Pathology and Development of a Targeted Therapeutic$373,750
R01 · FY2019 · HL · contact PI
Mechanisms for Sex Differences in CVD Pathology and Development of a Targeted Therapeutic$462,442
R01 · FY2018 · HL · contact PI
The mTORCI-miR-29-AT2R axis in cardiovascular diseases$372,773
R01 · FY2017 · HL · contact PI
The mTORCI-miR-29-AT2R axis in cardiovascular diseases$372,944
R01 · FY2016 · HL · contact PI
The mTORCI-miR-29-AT2R axis in cardiovascular diseases$419,680
R01 · FY2015 · HL · contact PI
The mTORCI-miR-29-AT2R axis in cardiovascular diseases$400,448
R01 · FY2014 · HL · contact PI
The mTORCI-miR-29-AT2R axis in cardiovascular diseases$52,993
R01 · FY2014 · HL · contact PI
The mTORCI-miR-29-AT2R axis in cardiovascular diseases$16,603
R01 · FY2014 · HL · contact PI
The mTORCI-miR-29-AT2R axis in cardiovascular diseases$355,414
R01 · FY2013 · HL · contact PI
Signaling Mechanisms of the Angll Receptor AT2$79,805
R15 · FY2003 · HL
Signaling Mechanisms of the Angll Receptor AT2$56,395
R15 · FY2003 · HL